A.T.S. Pharmaceuticals

A.T.S. Pharmaceuticals, also known as Advanced Topical Solutions Pharmaceuticals, was a specialty pharmaceutical division of Auriga Laboratories focused on the dermatology market. The company specialized in the development and commercialization of topical prescription products for conditions such as atopic dermatitis and localized pain. Its primary product portfolio included Zytopic Cream for dermatitis and Xyralid for pain management. The company operated through a unique commission-based sales model to reach specialized physicians, including dermatologists and gastroenterologists. Following the financial difficulties and eventual bankruptcy of its parent company, Auriga Laboratories, around 2010, the division's operations ceased.